Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  EXMceuticals Inc.    EXM   CA30207T1049

EXMCEUTICALS INC.

(EXM)
Delayed Quote. Delayed CANADIAN NATIONAL STOCK EXCHANGE - 02/14 03:42:27 pm
0.3 CAD   -14.29%
02/06EXMceuticals Inc. appoints Michael Kinley as CFO
GL
02/03EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor
GL
01/20EXMceuticals Inc. appoints Nick Davis as Board Advisor
GL
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

EXMceuticals : ProvidesáBi-Weekly Default Status Report

share with twitter share with LinkedIn share with facebook
share via e-mail
11/12/2019 | 08:01pm EST

VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”) is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). On October 23, 2019, the Company announced that, for reasons set out in its news release of October 23, 2019, the filing of its annual audited financial statements for the year ended June 30, 2019, the accompanying management’s discussion and analysis and the related CEO and CFO certifications (collectively, the “Annual Filings”) would not be filed by the prescribed deadline of October 28, 2019.

On October 29, 2019, the British Columbia Securities Commission, as principal regulator, granted a temporary management cease trade order (the “MCTO”).  As previously announced, the Company requires additional time to file its annual financial statements and MD&A for the financial year ended June 30, 2019 due to this being the first annual financial statements of the consolidated company following an RTO and additional time is required to complete the review and procedures. As a result, the Company concluded that it would not be in a position to complete the year-end audit within the time periods required by National Instrument 51-102. The Company currently anticipates that it will be in a position to file the Annual Filings on or before December 27, 2019.

Pursuant to NP 12-203, the Company must file bi-weekly default status reports in the form of further news releases during the period of the MCTO. The Company reports that since its news release of October 23, 2019, there have been no material changes regarding the information contained in that news release. The Company confirms there have been no failures by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines under NP 12-203, and there has not been, nor is there anticipated to be, any specified default subsequent to the default announced in the Company’s news release of October 23, 2019. The Company also confirms that there is no other material information concerning the affairs of the Company that has not been generally disclosed as of the date of this news release.

ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.

Jonathan Summers, Chairman and Director

For further information contact:
Investor Relations
Email: investors@exmceuticals.com

Media Enquiries:
Email: media@exmceuticals.com
Europe - Jane Glover:  +44 (0) 203 757 4990
North America - Mélanie Guillemette: +1 819 668 2734

FOR MORE UPDATES ON THE COMPANY

Follow us on Twitter: https://twitter.com/EXMceuticals
Follow us on LinkedIn: https://www.linkedin.com/company/exmceuticals/

Neither the CSE nor the FSE has approved nor disapproved the contents of this news release.  Neither the CSE, nor the FSE accepts responsibility for the adequacy or accuracy of this release.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to risks and uncertainties. Forward looking statements in this news release include, but are not limited to, the Company’s intent to file the Annual Filings. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statement will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

exm_logo.png

Source: EXMceuticals Inc.

2019 GlobeNewswire, Inc., source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on EXMCEUTICALS INC.
02/06EXMceuticals Inc. appoints Michael Kinley as CFO
GL
02/03EXMceuticals Inc. appoints Prf. Dr. Eurico Castro Alves as Board Advisor
GL
01/20EXMceuticals Inc. appoints Nick Davis as Board Advisor
GL
01/14EXMCEUTICALS INC : . names Paulo Martins as Chief Executive Officer for Portugal..
AQ
2019EXMceuticals Inc. Provides Corporate Update
GL
2019EXMCEUTICALS : Provides Bi-Weekly Default Status Report
AQ
2019EXMCEUTICALS : ProvidesáBi-Weekly Default Status Report
AQ
2019EXMceuticals Inc. announces appointment of new CEO
GL
2019EXMCEUTICALS : ProvidesáBi-Weekly Default Status Report
AQ
2019EXMCEUTICALS : GrantedáManagement Cease Trade Order
AQ
More news
Chart EXMCEUTICALS INC.
Duration : Period :
EXMceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Jonathan Summers Non-Independent Executive Chairman & CEO
Tanek Amin Chief Operating Officer
Morten Borch Independent Director
Bobby Doyon Non-Independent Director & Legal Counsel
Marc Bernier Director
Sector and Competitors
1st jan.Capitalization (M$)
EXMCEUTICALS INC.-39.39%9
CANOPY GROWTH CORPORATION9.78%7 910
BEIJING TONGRENTANG CO., LTD-2.45%5 397
CURALEAF HOLDINGS, INC.2.32%3 054
DONG-E-E-JIAO CO LTD--.--%2 951
CRONOS GROUP INC.-2.81%2 551